H35.133 Retinopathy of prematurity, stage 2, bilateral

Name of the Condition

• Retinopathy of prematurity, stage 2, bilateral

Summary

Retinopathy of prematurity (ROP) is a disorder affecting premature infants, characterized by abnormal blood vessel development in the retina. Stage 2 represents a mild to moderate phase where abnormal blood vessel growth is present but not yet severe. This stage may involve structural changes in the retina, such as a ridge or demarcation line, and requires monitoring to assess progression. Vision loss is uncommon at this stage, but timely intervention can prevent advancement to more severe forms.

Causes

ROP is caused by the incomplete growth of retinal blood vessels in premature infants. The retina, which normally develops blood vessels by full-term birth, may not have fully vascularized in preterm infants. Factors such as oxygen therapy, fluctuations in oxygen levels, and the infant's overall immaturity contribute to abnormal vessel growth. Stage 2 reflects a transitional phase where vascular changes are evident but not yet advanced.

Risk Factors

• Prematurity (especially infants born before 31 weeks of gestation).
• Low birth weight (typically under 1500 grams).
• Oxygen therapy or fluctuations in oxygen levels during neonatal care.
• Multiple births (e.g., twins or triplets).
• Certain medical conditions affecting oxygen delivery or retinal development.

Symptoms

In stage 2, ROP is often asymptomatic, as infants cannot communicate visual changes. Clinical signs may include a visible ridge or demarcation line in the retina during examination. Bilateral involvement means both eyes are affected, but severity can vary between them.

Diagnosis

Diagnosis is made through a dilated eye examination by a pediatric ophthalmologist, typically using indirect ophthalmoscopy. The stage and extent of ROP are documented based on retinal findings. Bilateral involvement is confirmed by examining both eyes, and staging follows standardized criteria (e.g., International Classification of ROP).

Treatment Options

Stage 2 ROP often requires close monitoring without immediate treatment, as it may resolve spontaneously. If progression occurs, treatment options include laser therapy or cryotherapy to ablate the avascular retina. Bilateral cases may necessitate treatment in one or both eyes, depending on severity.

Prognosis and Follow-Up

Prognosis for stage 2 ROP is generally favorable, with many cases regressing without intervention. However, regular follow-up is critical to detect progression. Infants are typically monitored every 1–2 weeks until the retina fully vascularizes or the condition stabilizes.

Complications

While vision loss is rare in stage 2, untreated progression can lead to retinal detachment, blindness, or other severe complications. Bilateral involvement increases the risk of long-term visual impairment if not managed appropriately.

Lifestyle & Prevention

Prevention focuses on optimizing neonatal care, including careful oxygen management and monitoring of preterm infants. No specific lifestyle modifications apply to infants, but maternal care (e.g., reducing preterm birth risk) indirectly supports prevention.

When to Seek Professional Help

Immediate evaluation by a pediatric ophthalmologist is warranted if ROP progresses to stage 3 or higher, or if symptoms like abnormal eye appearance or vision issues emerge. Early intervention is key to preventing irreversible damage.

Tips for Medical Coders

Use H35.133 for bilateral stage 2 ROP. Document the bilateral nature and stage clearly in clinical notes. Ensure differentiation from unilateral or higher-stage ROP to avoid miscoding. Follow ICD-10-CM guidelines for specificity in reporting eye involvement.